|
Status |
Public on Mar 06, 2008 |
Title |
ATF6-MER TG mouse_tamoxifen1 |
Sample type |
RNA |
|
|
Source name |
TG mouse_left ventricle_tamoxifen treated_1
|
Organism |
Mus musculus |
Characteristics |
Strain: C57BL6 Transgenic ATF6-MER Gender: male Age: 40 weeks Tissue: left ventricle Treatment: tamoxifen
|
Extracted molecule |
total RNA |
Extraction protocol |
Tel-Test Inc RNAzol protocol
|
Label |
biotin
|
Label protocol |
See Affymetrix genechip expression analysis protocol
|
|
|
Hybridization protocol |
See Affymetrix genechip expression analysis protocol
|
Scan protocol |
See Affymetrix genechip expression analysis protocol
|
Description |
See Affymetrix genechip expression analysis protocol
|
Data processing |
See Affymetrix genechip expression analysis protocol
|
|
|
Submission date |
Jun 26, 2007 |
Last update date |
Aug 28, 2018 |
Contact name |
Peter J Belmont |
Organization name |
Pfizer
|
Street address |
10724 Science Center Drive
|
City |
San Diego |
State/province |
CA |
ZIP/Postal code |
92121 |
Country |
USA |
|
|
Platform ID |
GPL1261 |
Series (1) |
GSE8322 |
Identification of MCIP1 as an ATF6-inducible ER Stress Response Gene in the Heart by Gene Expression Profiling |
|
Relations |
Reanalyzed by |
GSE119085 |